NOXXON
Live / Registered — Registered and renewed (as of 16 Dec 2023)
What this means for you
Registered since 21 Oct 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Oct 2023).
Record
- Serial number
- 75764580
- Registration number
- 2775977
- Mark type
- Word mark
- Filed
- 30 Jul 1999
- Published for opposition
- 24 Jul 2001
- Registered
- 21 Oct 2003
- Next maintenance due
- 21 Oct 2023
- Attorney of record
- Jody H. Drake
Goods and services
- Class 001 — Chemicals: COMPOUNDS CONSISTING IN WHOLE OR IN PART OF NUCLEIC ACIDS OR DERIVATIVES THEREOF AND L-NUCLEOTIDES FOR USE IN MANUFACTURING PHARMACEUTICALS
- Class 042 — Scientific and technological services: RESEARCH AND DEVELOPMENT OF PHARMACEUTICALS AND CHEMICAL COMPOUNDS, ALSO COMPRISING AFFINITY MEDIA, FOR OTHERS
Owner
- TME PHARMA AG, Berlin, DE
- NOXXON Pharma AG, 10589 Berlin, DE
- NOXXON Pharma AG, 10589 Berlin, DE
- NOXXON Pharma AG, 13355 Berlin, DE
Prosecution history
- 16 Dec 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Dec 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 16 Dec 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Dec 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Jun 2023 — TEAS SECTION 8 & 9 RECEIVED
- 02 Nov 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Oct 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 29 Aug 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Aug 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 29 Aug 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Aug 2013 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 29 Aug 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Aug 2013 — TEAS SECTION 8 & 9 RECEIVED
- 09 Oct 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Oct 2009 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL